Risk factors for early primary graft dysfunction after lung transplantation: A registry study

Clinical Transplantation

Volumn 23, Issue 6, 2009, Pages 819-830

  Kuntz, Catherine L ^a   Hadjiliadis, Denis ^a   Ahya, Vivek N ^a   Kotloff, Robert M ^a   Pochettino, Alberto ^a   Lewis, James ^a   Christie, Jason D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute lung injury; Lung transplantation; Primary graft dysfunction; Reperfusion injury; Risk factors

Indexed keywords

PRESERVATIVE;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DONOR; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HEAD INJURY; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INCIDENCE; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGISTER; RISK FACTOR; SEX DIFFERENCE; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; MIDDLE AGED; MORBIDITY; PROCEDURES; REPERFUSION INJURY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TIME; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; REGISTRIES; REPERFUSION INJURY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 70350442470     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00951.x     Document Type: Article

References (48)

1. Christie JD, Bavaria JE, Palevsky HI. Primary graft failure following lung transplantation. Chest 1998, 114:51.
2. Thabut G, Vinatier I, Stern JB. Primary graft failure following lung transplantation: predictive factors of mortality. Chest 2002, 121:1876.
3. Sommers KE, Griffith BO, Hardesty RL, Keenan RJ. Early lung allograft dysfunction in twin recipients from the same donor: risk factor analysis. Ann Thorac Surg 1996, 62:784.
4. King RC, Binns OA, Rodruigez F. Reperfusion injury significantly impacts on clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000, 69:1681.
5. Christie JD, Kotloff RM, Pochettino A. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003, 124:1232.
6. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest 2000, 118:1255.
7. Fisher AJ, Donnelly SC, Hirani N. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 1999, 353:1412.
8. Kahn SU, Salloum J, O'Donovan PB. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 1999, 116:187.
9. Christie JD, Kotloff RM, Ahya VN. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005, 171:1312.
10. Whitson BA, Nath DS, Johnson AC. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006, 131:73.
11. Boujoukos AJ, Martich GD, Vega JD, Keenan RJ, Griffith BP. Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema. J Heart Lung Transplant 1997, 16:439.
12. Thabut G, Vinatier I, Brugiere O. Influence if preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 2001, 164:1204.
13. Rabanal JM, Ibañez AM, Mons R. Influence of preservation solution on early lung function (Eurocollins versus Perfadex). Transplant Proc 2003, 35:4438.
14. Keshavjee SH, Yamazaki F, Cardoso PF, McRitchie DI, Patterson GA, Cooper JD. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg 1989, 98:529.
15. Yamazaki F, Yokomise H, Keshavjee SH. The superiority of an extracellular fluid solution over Eurocollins solution for pulmonary preservation. Transplantation 1990, 49:690.
16. Sakamaki F, Hoffmann H, Müller C, Dienemann H, Messmer K, Schildberg FW. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low potassium dextran solution for lung preservation. Am J Respir Crit Care Med 1997, 156:1073.
17. Struber M, Hohlfeld JM, Fraund S, Kim P, Warnecke G, Haverich A. Low potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg 2000, 120:566.
18. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003, 167:490.
19. Fischer S, Matte-Martyn A, De Perrot M. Low potassium dextran solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001, 121:594.
20. Thabut GH, Mal H, Cerrina J. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005, 171:786.
21. Moldanado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993, 138:923.
22. Follete DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998, 17:423.
23. de Perrot M, Sekine Y, Fischer S. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002, 165:211.
24. Hertz MI, Taylor DO, Trulock EP. The registry of the International Society for Heart and Lung Transplantation: nineteenth official report. J Heart Lung Transplant 2002, 21:950.
25. Fisher AJ, Donnelly SC, Hirani N. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001, 163:259.
26. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 2003, 75:1928.
27. Padilla J, Calco V, Pastor J, Blasco E, Paris F. Single-lung transplant and primary graft failure. Arch Bronchoneumol 2002, 38:16.
28. McKeating E, Andrews PJ, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain-injury. Br J Anaesth 1997, 78:520.
29. Takada M, Nadeua KC, Hancock WW. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998, 65:1533.
30. Murphy SJ, McCullough LD, Smith JM. Stroke in the female: role of biological sex and estrogen. ILAR 2004, 45:147.
31. Eckhoff DE, Bilbao G, Frenette L, Thompson JA, Contreras JL. 17-beta-estradiol protects the liver against warm ischemia-reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha. Surgery 2002, 132:302.
32. Cross HR, Murphy E, Kocj WJ, Steenbergen C. Male and female mice overexpressing the beta(2)-adrenergic receptor exhibit differences in ischemia-reperfusion injury: role of nitric oxide. Cardiovasc Res 2002, 53:662.
33. Yang SH, Perez E, Cutright J. Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Phys 2002, 92:195.
34. Schwarzenberger JC, Sun LS, Pesce MA. Sex-based differences in serum cardiac troponin I, a specific marker for myocardial injury after cardiac surgery. Crit Care Med 2003, 31:689.
35. Imahara SD, Jelacic S, Junker CE, O'Keefe GE. The influence of gender on human innate immunity. Surgery 2005, 138:275.
36. Scornik JC, Zander DS, Baz MA, Donnelly WH, Staples ED. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. Transplantation 1999, 68:1542.
37. Hadjiliadis D, Chaparro C, Reinsmoen NL. Pretransplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant 2005, 24:S249.
38. Kopko PM, Paglieroni TG, Popovsky A, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 2003, 43:177.
39. Seeger W, Schneider U, Kreusler B. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990, 76:1438.
40. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001, 41:1244.
41. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous?. Transfusion 2001, 41:317.
42. Roberts DH, Wain JC, Chang Y, Ginns LC. Donor-recipient gender mismatch in lung transplantation: impact on obliterative bronchiolitis and survival. J Heart Lung Transplant 2004, 23:1252.
43. Sato M, Gutierrez C, Kaneda H, Liu M, Waddell TK, Keshavjee S. The effect of gender combinations on outcome in human lung transplantation: the International Society of Heart and Lung Transplantation Registry experience. J Heart Lung Transplant 2006, 25:624.
44. Thakker GD, Frangogiannis NG, Bujak M. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 291:H2504.
45. Mathur A, Maher B, Denmark SE. Cytokine profile after lung transplantation: correlation with allograft injury. Ann Thorac Surg 2006, 82:0844.
46. Shibata R, Sato K, Pimentel DR. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005, 11:1096.
47. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006, 16:141.
48. Culver SA, Mazzone PJ, Khandwala F. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant 2005, 24:137.